Pro: Can biomarkers be gold standards in Alzheimer's disease?
Open Access
- 1 January 2010
- journal article
- viewpoint
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 2 (3) , 17
Abstract
Recent advances in biomarkers for Alzheimer's disease (AD) now allow the visualization of one of the hallmark pathologies of AD in vivo, and combination biomarker profiles can now approximate the diagnostic accuracy of autopsy in patients with dementia. Biomarkers are already employed in clinical trials in prodromal AD for both subject selection and in monitoring therapeutic response. Ultimately the greatest utility of biomarkers may be in the preclinical stages of AD, to identify and track progression of the disease prior to significant cognitive impairment, at the point when disease modifying therapies are likely to be most efficacious.Keywords
This publication has 16 references indexed in Scilit:
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose studyThe Lancet Neurology, 2010
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeThe Lancet Neurology, 2010
- Conversion of amyloid positive and negative MCI to AD over 3 yearsNeurology, 2009
- MRI and CSF biomarkers in normal, MCI, and AD subjectsNeurology, 2009
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without DementiaNeuron, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Amyloid imaging in mild cognitive impairment subtypesAnnals of Neurology, 2009
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjectsBrain, 2008
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 2007
- Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical DementiaArchives of Neurology, 2006